<VariationArchive RecordType="classified" VariationID="16105" VariationName="NC_000001.11:g.(?_42925375)_(42959176_?)del" VariationType="Deletion" Accession="VCV000016105" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-30" DateCreated="2017-04-21" MostRecentSubmission="2023-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31144" VariationID="16105">
      <GeneList>
        <Gene Symbol="LOC121725020" FullName="Sharpr-MPRA regulatory region 3978" GeneID="121725020" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42952598" stop="42952892" display_start="42952598" display_stop="42952892" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930362" FullName="ATAC-STARR-seq lymphoblastoid active region 902" GeneID="129930362" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42932139" stop="42932308" display_start="42932139" display_stop="42932308" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930363" FullName="ATAC-STARR-seq lymphoblastoid active region 903" GeneID="129930363" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42936813" stop="42936882" display_start="42936813" display_stop="42936882" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930364" FullName="ATAC-STARR-seq lymphoblastoid active region 906" GeneID="129930364" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42944597" stop="42944646" display_start="42944597" display_stop="42944646" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930365" FullName="ATAC-STARR-seq lymphoblastoid active region 907" GeneID="129930365" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42945077" stop="42945206" display_start="42945077" display_stop="42945206" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930366" FullName="ATAC-STARR-seq lymphoblastoid active region 908" GeneID="129930366" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42945297" stop="42945456" display_start="42945297" display_stop="42945456" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930367" FullName="ATAC-STARR-seq lymphoblastoid active region 909" GeneID="129930367" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42952406" stop="42952475" display_start="42952406" display_stop="42952475" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930368" FullName="ATAC-STARR-seq lymphoblastoid active region 910" GeneID="129930368" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42955422" stop="42955711" display_start="42955422" display_stop="42955711" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129930369" FullName="ATAC-STARR-seq lymphoblastoid silent region 772" GeneID="129930369" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42957989" stop="42958628" display_start="42957989" display_stop="42958628" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SLC2A1-DT" FullName="SLC2A1 divergent transcript" GeneID="440584" HGNC_ID="HGNC:44187" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42959049" stop="42983358" display_start="42959049" display_stop="42983358" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000001.11:g.(?_42925375)_(42959176_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" innerStart="42925375" innerStop="42959176" display_start="42925375" display_stop="42959176" variantLength="33802" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="43391046" innerStop="43424847" display_start="43391046" display_stop="43424847" variantLength="33802" Strand="-" />
      </Location>
      <OtherNameList>
        <Name>SLC2A1, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.(?_42925375)_(42959176_?)del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.(?_42925375)_(42959176_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_43391046)_(43424847_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_43391046)_(43424847_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="138140.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion of gene SLC2A1.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.11:g.(?_42925375)_(42959176_?)del AND Encephalopathy due to GLUT1 deficiency" Accession="RCV000017485" Version="28">
        <ClassifiedConditionList TraitSetID="5230">
          <ClassifiedCondition DB="MedGen" ID="C4551966">Encephalopathy due to GLUT1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-04-21" MostRecentSubmission="2023-12-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10980529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24847886</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9462754</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5230" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">De Vivo disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transport defect, blood-brain barrier</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transporter protein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Encephalopathy due to GLUT1 deficiency</ElementValue>
                <XRef ID="MONDO:0011724" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1, infantile onset, severe</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS1</ElementValue>
                <XRef Type="MIM" ID="606777" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9265" />
                <XRef ID="9265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="71277" DB="Orphanet" />
              <XRef ID="C4551966" DB="MedGen" />
              <XRef ID="MONDO:0011724" DB="MONDO" />
              <XRef Type="MIM" ID="606777" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37757" SubmissionDate="2017-03-25" DateLastUpdated="2023-12-17" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138140.0001_GLUT1 DEFICIENCY SYNDROME 1" title="SLC2A1, DEL_GLUT1 DEFICIENCY SYNDROME 1" />
        <ClinVarAccession Accession="SCV000037757" DateUpdated="2023-12-17" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient originally reported by De Vivo et al. (1991) with severe manifestations related to a demonstrable defect in glucose transport across the blood-brain barrier (GLUT1DS1; 606777), Seidner et al. (1998) identified a heterozygous deletion of the GLUT1 gene. The deletion appeared to be a de novo mutation.</Attribute>
              <Citation>
                <CitationText>Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., Yan, N. Crystal structure of the human glucose transporter GLUT1. Nature 510: 121-125, 2014.</CitationText>
              </Citation>
              <Citation>
                <CitationText>Seidner, G., Alvarez, M. G., Yeh, J.-I., O'Driscoll, K. R., Klepper, J., Stump, T. S., Wang, D., Spinner, N. B., Birnbaum, M. J., De Vivo, D. C. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nature Genet. 18: 188-191, 1998.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="606777" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Wang et al. (2000) identified 1 patient who was hemizygous for the GLUT1 gene.</Attribute>
              <Citation>
                <CitationText>Wang, D., Kranz-Eble, P., De Vivo, D. C. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum. Mutat. 16: 224-231, 2000. Note: Erratum: Hum. Mutat. 16: 527 only, 2000.</CitationText>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <Name>SLC2A1, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138140.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUT1 DEFICIENCY SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37757" TraitType="Disease" MappingType="Name" MappingValue="GLUT1 DEFICIENCY SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C4551966" Name="Encephalopathy due to GLUT1 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

